HK Stock MarketDetailed Quotes

80883 CNOOC-R

Watchlist
  • 15.820
  • -0.040-0.25%
Trading Dec 2 11:42 CST
751.92BMarket Cap5.26P/E (TTM)

CNOOC-R Key Stats

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Turnover
6.26%326.02B
18.07%226.77B
14.08%111.47B
-1.33%416.61B
-1.39%306.82B
-5.09%192.06B
7.50%97.71B
71.56%422.23B
--311.15B
83.57%202.36B
Operating income
6.26%326.02B
18.07%226.77B
14.08%111.47B
-1.33%416.61B
-1.39%306.82B
-5.09%192.06B
7.50%97.71B
71.56%422.23B
311.15B
83.57%202.36B
Operating expenses
3.98%-148.5B
-4.61%-51.91B
-9.15%-154.65B
-31.18%-49.63B
-141.69B
Gross profit
16.66%177.53B
23.85%59.55B
-10.20%152.17B
-9.39%48.08B
169.46B
Selling expenses
1.11%-2.59B
-4.63%-5.22B
-1.14%-884M
-4.62%-10.95B
-5.60%-2.62B
-13.98%-4.99B
-13.51%-874M
-16.82%-10.47B
---2.48B
-13.07%-4.38B
Administrative expenses
-5.40%-5.03B
----
-22.51%-1.62B
----
-16.41%-4.78B
----
-7.12%-1.32B
----
---4.1B
----
Research and development expenses
-2.78%-1.22B
----
4.27%-336M
----
-46.43%-1.19B
----
-56.00%-351M
----
---812M
----
Profit from asset sales
1,350.00%25M
----
50.00%3M
----
-114.29%-2M
----
-33.33%2M
----
--14M
----
Depreciation and amortization
----
-11.31%-37.56B
----
-9.70%-68.95B
----
-14.34%-33.74B
----
-9.81%-62.85B
----
-2.04%-29.51B
Revaluation surplus
102.90%980M
----
-89.87%56M
----
222.00%483M
----
1,070.18%553M
----
--150M
----
-Changes in the fair value of other assets
102.90%980M
----
-89.87%56M
----
222.00%483M
----
1,070.18%553M
----
--150M
----
Impairment and provision
85.89%-45M
88.67%-34M
-2,400.00%-25M
-440.09%-3.6B
-184.82%-319M
-191.26%-300M
66.67%-1M
91.63%-666M
---112M
-80.70%-103M
-Other impairment is provision
85.89%-45M
88.67%-34M
-2,400.00%-25M
-440.09%-3.6B
-184.82%-319M
-191.26%-300M
66.67%-1M
91.63%-666M
---112M
-80.70%-103M
Special items of operating profit
-60.01%1.6B
-12.69%-68.06B
-36.79%615M
-3.58%-141.01B
1.35%3.99B
2.72%-60.39B
666.14%973M
-110.07%-136.14B
--3.94B
-129.43%-62.08B
Operating profit
16.36%155.83B
25.24%105.54B
20.76%52.29B
-13.22%167.77B
-11.90%133.92B
-13.18%84.27B
-7.16%43.3B
101.42%193.33B
152B
113.57%97.06B
Financing income
----
12.91%2.6B
----
61.24%4.81B
----
106.28%2.3B
----
122.22%2.98B
----
105.72%1.12B
Financing cost
-91.67%-1.43B
-18.86%-3.33B
532.65%310M
11.17%-5.35B
65.75%-744M
9.82%-2.8B
107.17%49M
-0.13%-6.03B
---2.17B
-9.41%-3.11B
Share of profits of associates
----
-4.96%402M
----
28.21%850M
----
40.07%423M
----
8.51%663M
----
-17.26%302M
Share of profit from joint venture company
----
-62.26%160M
----
-13.38%1.08B
----
-24.69%424M
----
570.94%1.25B
----
441.35%563M
Special items of earning before tax
93.52%-14M
-79.87%403M
23.08%-60M
48.12%3.82B
-61.19%-216M
2.19%2B
-178.57%-78M
-38.16%2.58B
---134M
45.00%1.96B
Earning before tax
16.12%154.39B
22.11%105.78B
21.42%52.54B
-11.19%172.97B
-11.18%132.96B
-11.52%86.62B
-5.79%43.27B
103.26%194.77B
149.69B
117.68%97.9B
Tax
-6.81%-37.7B
-13.80%-26.03B
-14.79%-12.81B
7.93%-48.88B
13.78%-35.3B
12.07%-22.87B
4.01%-11.16B
-108.09%-53.09B
---40.94B
-123.36%-26.02B
After-tax profit from continuing operations
19.48%116.68B
25.09%79.75B
23.72%39.73B
-12.41%124.09B
-10.21%97.66B
-11.32%63.75B
-6.39%32.11B
101.51%141.68B
108.76B
115.70%71.88B
Earning after tax
19.48%116.68B
25.09%79.75B
23.72%39.73B
-12.41%124.09B
-10.21%97.66B
-11.32%63.75B
-6.39%32.11B
101.51%141.68B
108.76B
115.70%71.88B
Minority profit
78.57%25M
207.69%14M
275.00%7M
1,173.91%247M
240.00%14M
-225.00%-13M
-300.00%-4M
-76.92%-23M
---10M
-33.33%-4M
Profit attributable to shareholders
19.47%116.66B
25.05%79.73B
23.69%39.72B
-12.60%123.84B
-10.23%97.65B
-11.30%63.76B
-6.38%32.11B
101.51%141.7B
108.77B
115.69%71.89B
Basic earnings per share
19.51%2.45
25.37%1.68
23.53%0.84
-14.19%2.6
-12.39%2.05
-14.65%1.34
-11.69%0.68
92.99%3.03
2.34
109.33%1.57
Diluted earnings per share
19.51%2.45
25.37%1.68
23.53%0.84
-14.19%2.6
-12.39%2.05
-14.65%1.34
-11.69%0.68
92.99%3.03
2.34
109.33%1.57
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
IAS and HKAS
CAS (2007)
IAS and HKAS
CAS (2007)
IAS and HKAS
CAS (2007)
IAS and HKAS
CAS (2007)
IAS and HKAS
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
Unqualified Opinion
--
--
Auditor
--
--
--
Ernst & Young Huaming (Special General Partnership), Ernst & Young
--
--
--
Ernst & Young Huaming (Special General Partnership), Ernst & Young
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Turnover 6.26%326.02B18.07%226.77B14.08%111.47B-1.33%416.61B-1.39%306.82B-5.09%192.06B7.50%97.71B71.56%422.23B--311.15B83.57%202.36B
Operating income 6.26%326.02B18.07%226.77B14.08%111.47B-1.33%416.61B-1.39%306.82B-5.09%192.06B7.50%97.71B71.56%422.23B311.15B83.57%202.36B
Operating expenses 3.98%-148.5B-4.61%-51.91B-9.15%-154.65B-31.18%-49.63B-141.69B
Gross profit 16.66%177.53B23.85%59.55B-10.20%152.17B-9.39%48.08B169.46B
Selling expenses 1.11%-2.59B-4.63%-5.22B-1.14%-884M-4.62%-10.95B-5.60%-2.62B-13.98%-4.99B-13.51%-874M-16.82%-10.47B---2.48B-13.07%-4.38B
Administrative expenses -5.40%-5.03B-----22.51%-1.62B-----16.41%-4.78B-----7.12%-1.32B-------4.1B----
Research and development expenses -2.78%-1.22B----4.27%-336M-----46.43%-1.19B-----56.00%-351M-------812M----
Profit from asset sales 1,350.00%25M----50.00%3M-----114.29%-2M-----33.33%2M------14M----
Depreciation and amortization -----11.31%-37.56B-----9.70%-68.95B-----14.34%-33.74B-----9.81%-62.85B-----2.04%-29.51B
Revaluation surplus 102.90%980M-----89.87%56M----222.00%483M----1,070.18%553M------150M----
-Changes in the fair value of other assets 102.90%980M-----89.87%56M----222.00%483M----1,070.18%553M------150M----
Impairment and provision 85.89%-45M88.67%-34M-2,400.00%-25M-440.09%-3.6B-184.82%-319M-191.26%-300M66.67%-1M91.63%-666M---112M-80.70%-103M
-Other impairment is provision 85.89%-45M88.67%-34M-2,400.00%-25M-440.09%-3.6B-184.82%-319M-191.26%-300M66.67%-1M91.63%-666M---112M-80.70%-103M
Special items of operating profit -60.01%1.6B-12.69%-68.06B-36.79%615M-3.58%-141.01B1.35%3.99B2.72%-60.39B666.14%973M-110.07%-136.14B--3.94B-129.43%-62.08B
Operating profit 16.36%155.83B25.24%105.54B20.76%52.29B-13.22%167.77B-11.90%133.92B-13.18%84.27B-7.16%43.3B101.42%193.33B152B113.57%97.06B
Financing income ----12.91%2.6B----61.24%4.81B----106.28%2.3B----122.22%2.98B----105.72%1.12B
Financing cost -91.67%-1.43B-18.86%-3.33B532.65%310M11.17%-5.35B65.75%-744M9.82%-2.8B107.17%49M-0.13%-6.03B---2.17B-9.41%-3.11B
Share of profits of associates -----4.96%402M----28.21%850M----40.07%423M----8.51%663M-----17.26%302M
Share of profit from joint venture company -----62.26%160M-----13.38%1.08B-----24.69%424M----570.94%1.25B----441.35%563M
Special items of earning before tax 93.52%-14M-79.87%403M23.08%-60M48.12%3.82B-61.19%-216M2.19%2B-178.57%-78M-38.16%2.58B---134M45.00%1.96B
Earning before tax 16.12%154.39B22.11%105.78B21.42%52.54B-11.19%172.97B-11.18%132.96B-11.52%86.62B-5.79%43.27B103.26%194.77B149.69B117.68%97.9B
Tax -6.81%-37.7B-13.80%-26.03B-14.79%-12.81B7.93%-48.88B13.78%-35.3B12.07%-22.87B4.01%-11.16B-108.09%-53.09B---40.94B-123.36%-26.02B
After-tax profit from continuing operations 19.48%116.68B25.09%79.75B23.72%39.73B-12.41%124.09B-10.21%97.66B-11.32%63.75B-6.39%32.11B101.51%141.68B108.76B115.70%71.88B
Earning after tax 19.48%116.68B25.09%79.75B23.72%39.73B-12.41%124.09B-10.21%97.66B-11.32%63.75B-6.39%32.11B101.51%141.68B108.76B115.70%71.88B
Minority profit 78.57%25M207.69%14M275.00%7M1,173.91%247M240.00%14M-225.00%-13M-300.00%-4M-76.92%-23M---10M-33.33%-4M
Profit attributable to shareholders 19.47%116.66B25.05%79.73B23.69%39.72B-12.60%123.84B-10.23%97.65B-11.30%63.76B-6.38%32.11B101.51%141.7B108.77B115.69%71.89B
Basic earnings per share 19.51%2.4525.37%1.6823.53%0.84-14.19%2.6-12.39%2.05-14.65%1.34-11.69%0.6892.99%3.032.34109.33%1.57
Diluted earnings per share 19.51%2.4525.37%1.6823.53%0.84-14.19%2.6-12.39%2.05-14.65%1.34-11.69%0.6892.99%3.032.34109.33%1.57
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)IAS and HKASCAS (2007)IAS and HKASCAS (2007)IAS and HKASCAS (2007)IAS and HKASCAS (2007)IAS and HKAS
Audit Opinions ------Unqualified Opinion------Unqualified Opinion----
Auditor ------Ernst & Young Huaming (Special General Partnership), Ernst & Young------Ernst & Young Huaming (Special General Partnership), Ernst & Young----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
% Chg

No Data